HIV Drug Resistance  Assessment  Among Women Who Seroconverted During  MTN025HOPE OpenLabel Extensive Dapivirine Viginal Ring Trial

dc.article.end-page41en
dc.article.start-page35en
dc.citation.doi10.1097/QAI.0000000000003308en
dc.contributor.authorU Parikhen
dc.contributor.authorK Penroseen
dc.contributor.authorA Heapsen
dc.contributor.authorR Sethien
dc.contributor.authorThesla Palanee-Philipsen
dc.contributor.authorE et alen
dc.date.accessioned2024-12-10T10:17:41Z
dc.date.available2024-12-10T10:17:41Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn1525-4135en
dc.identifier.urihttps://hdl.handle.net/10539/43247
dc.journal.titleHIV Drug Resistance  Assessment  Among Women Who Seroconverted During  MTN025HOPE OpenLabel Extensive Dapivirine Viginal Ring Trialen
dc.journal.volume95en
dc.publisherLIPPINCOTT WILLIAMS & WILKINSen
dc.titleHIV Drug Resistance  Assessment  Among Women Who Seroconverted During  MTN025HOPE OpenLabel Extensive Dapivirine Viginal Ring Trialen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
208.18 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client